Clolar Side Effects
View Community-reported Clolar side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Clolar Side Effect
Have You dealt with a Clolar side effect? Share your experience
Clolar Side Effects summary
Total Clolar reports: 74.Clolar FDA safety alerts: No.
Reported deaths: 37 Reported hospitalizations: 39.
Take Clolar Side Effects Survey, Discuss Clolar with others
Clolar Side Effects: hypotension, haemodialysis, headache, pain in extremity, escherichia infection, anal fistula, agitation, capillary leak syndrome, palmar-plantar erythrodysaesthesia syndrome, blood bilirubin increased, blood culture positive,
Clolar Usage.
If you have questions about Clolar, you can ask a Health Expert or Ask Patient Community about Clolar.
Clolar Side Effects reported to FDA
Showing 1-40 of 74 Next >
Clolar Side Effects Report #5760328-XPhysician from UNITED STATES reported CLOLAR problem on May 22, 2008. Female patient, 60 years of age, weighting 193.1 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: ascites, deep vein thrombosis, venoocclusive disease. CLOLAR dosage: 30 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5764138-9
CLOLAR problem was reported by a Physician from UNITED STATES on May 30, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dialysis, enterococcal infection, enterococcal sepsis, neutropenic sepsis, renal failure, respiratory failure, staphylococcal infection, staphylococcal sepsis. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ALBUTEROL SULPHATE, ESCITALOPRAM OXALATE. Patient died on 04/08/2008.
Clolar Side Effects Report #5765183-X
Physician from UNITED STATES reported CLOLAR problem on May 29, 2008. Female patient, 68 years of age, weighting 183.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, alanine aminotransferase increased, arrhythmia supraventricular, aspartate aminotransferase increased, diarrhoea, dyspnoea, hypoalbuminaemia, hypokalaemia. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 05/20/2008.
Clolar Side Effects Report #5765184-1
CLOLAR problem was reported by a Physician from UNITED STATES on May 27, 2008. Female patient, 60 years of age, weighting 233.7 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, rash. CLOLAR dosage: unknown. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5767144-3
Physician from UNITED STATES reported CLOLAR problem on June 03, 2008. Male patient, 72 years of age, was diagnosed with myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bundle branch block right, cardio-respiratory arrest, liver function test abnormal, pulse absent, sepsis, tachycardia. CLOLAR dosage: unknown. During the same period patient was treated with CYTARABINE. Patient died on 05/29/2008.
Clolar Side Effects Report #5775065-5
CLOLAR problem was reported by a Physician from UNITED STATES on June 04, 2008. Female patient, 60 years of age, weighting 233.7 lb, was diagnosed with myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, graft versus host disease. CLOLAR dosage: 67 MG, QDX5, INTRAVENOUS. During the same period patient was treated with MICAFUNGIN. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5776285-6
Health Professional from UNITED STATES reported CLOLAR problem on June 06, 2008. Female patient, 60 years of age, weighting 193.1 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, acute myeloid leukaemia recurrent, deep vein thrombosis, haemosiderosis, hepatocellular injury, hyperglycaemia, hypermagnesaemia, liver injury, no therapeutic response. CLOLAR dosage: 53 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5787472-5
CLOLAR problem was reported by a Physician from UNITED STATES on June 12, 2008. Female patient, 60 years of age, weighting 199.7 lb, was diagnosed with myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, culture urine positive, dysuria, enterococcal infection, graft versus host disease, intervertebral disc protrusion, micturition urgency, pseudomonas infection. CLOLAR dosage: 67 MG, QDX5, INTRAVENOUS. During the same period patient was treated with PHENYTOIN, MICAFUNGIN, DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE, AZTREONAM. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5796283-6
Physician from UNITED STATES reported CLOLAR problem on June 24, 2008. Female patient, 68 years of age, weighting 183.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, diarrhoea, dyspnoea, hypoalbuminaemia, hypokalaemia, hyponatraemia, hypotension, nodal arrhythmia. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, ATENOLOL, DIFLUCAN, CIPRO, ALLOPURINOL, MAGNESIUM SULPHATE, CHLORHEXIDINE GLUCONATE. Patient was hospitalized. Patient died on 05/20/2008.
Clolar Side Effects Report #5796644-5
CLOLAR problem was reported by a Consumer or non-health professional from UNITED STATES on June 30, 2008. Female patient, weighting 198.4 lb, was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, bacterial infection, blood culture positive, blood fibrinogen increased, blood pressure systolic decreased, catheter site haemorrhage, clostridium difficile toxin test positive, disseminated intravascular coagulation. CLOLAR dosage: 390 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5733313-1
Physician from UNITED STATES reported CLOLAR problem on Apr 28, 2008. Male patient, 60 years of age, weighting 197.3 lb, was diagnosed with myelodysplastic syndrome and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, diarrhoea, liver function test abnormal, oedema, pericardial effusion, rash. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, THYMOGLOBULIN, NORVASC, CEFEPIME, NEXIUM, FLUCONAZOLE, FLONASE. Patient recovered.
Clolar Side Effects Report #5734935-4
CLOLAR problem was reported by a Physician from UNITED STATES on May 02, 2008. Male patient, 60 years of age, weighting 197.3 lb, was diagnosed with myelodysplastic syndrome and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, bone marrow transplant, chest pain, diarrhoea, dilatation ventricular, dyspnoea, ebstein's anomaly, liver function test abnormal, oedema. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, THYMOGLOBULINE, NORVASC, CEFEPIME, NEXIUM, FLUCONAZOLE, FLONASE, COMPAZINE. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5738493-X
Physician from UNITED STATES reported CLOLAR problem on May 07, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dialysis, enterococcal infection, hypoxia, neutropenic infection, renal failure, respiratory failure, sepsis syndrome, staphylococcal infection. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ESCITALOPRAM. Patient died on 04/08/2008.
Clolar Side Effects Report #5741054-X
CLOLAR problem was reported by a Physician from UNITED STATES on May 07, 2008. Female patient, 69 years of age, weighting 146.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: agitation, blood creatinine increased, blood potassium decreased, cardiac failure congestive, cardiomegaly, diarrhoea, hallucination, auditory, hallucination, visual. CLOLAR dosage: 76 MG,QD; INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN, DILANTIN KAPSEAL. Patient was hospitalized. Patient died on 05/06/2008.
Clolar Side Effects Report #5748658-9
Physician from UNITED STATES reported CLOLAR problem on May 16, 2008. Male patient, 72 years of age, was diagnosed with myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bundle branch block right, cardio-respiratory arrest, liver function test abnormal, pulse absent, tachycardia. CLOLAR dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Clolar Side Effects Report #5752298-5
CLOLAR problem was reported by a Physician from UNITED STATES on Apr 15, 2008. Male patient, child 12 years of age, weighting 80.25 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cardiomyopathy, cardiovascular disorder, chest pain, coagulopathy, dialysis, fat necrosis, febrile neutropenia. CLOLAR dosage: 36 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NALOXONE, HYDROCORTISONE, VANCOMYCIN HYDROCHLORIDE, HYDROMORPHONE. Patient was hospitalized. Patient died on 01/10/2008.
Clolar Side Effects Report #5755495-8
Consumer or non-health professional from UNITED STATES reported CLOLAR problem on May 30, 2008. Female patient, weighting 183.0 lb, was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, diarrhoea, dyspnoea, erythema, hypoalbuminaemia, hypotension, oedema peripheral. CLOLAR dosage: 360 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5756605-9
CLOLAR problem was reported by a Physician from UNITED STATES on May 20, 2008. Female patient, 69 years of age, weighting 146.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: agitation, cardiac failure congestive, cardiomegaly, cerebral ischaemia, diarrhoea, disorientation, dyspnoea. CLOLAR dosage: 76 MG, QD, INTRAVENOUS. During the same period patient was treated with CAMPATH, MELPHALAN, DILANTIN KAPSEAL, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, FERROUS SULPHATE, ALLOPURINOL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 05/06/2008.
Clolar Side Effects Report #5694161-4
Physician from UNITED STATES reported CLOLAR problem on Mar 27, 2008. Female patient, 14 years of age, weighting 95.90 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, bronchopulmonary aspergillosis, gastrointestinal infection, hypoxia, respiratory distress, respiratory tract infection, urinary tract infection. CLOLAR dosage: 20 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYCLOSPORIN, DIPHENHYDRAMINE. Patient died on 03/14/2008.
Clolar Side Effects Report #5702488-2
CLOLAR problem was reported by a Physician from UNITED KINGDOM on Mar 26, 2008. Male patient, 66 years of age, was diagnosed with acute leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multi-organ failure, sepsis. CLOLAR dosage: 80 MG/DAY, QDX5, INTRAVENOUS. Patient died on 12/22/2007.
Clolar Side Effects Report #5702490-0
Physician from GERMANY reported CLOLAR problem on Apr 02, 2008. Female patient was diagnosed with acute lymphocytic leukaemia, neuroblastoma, rhabdomyosarcoma and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, creatinine renal clearance, diarrhoea, disease recurrence, malignant neoplasm progression, mucosal inflammation, pneumonitis. CLOLAR dosage: 50 MG/M2, QD, INTRAVENOUS. Patient died.
Clolar Side Effects Report #5708870-1
CLOLAR problem was reported by a Physician from UNITED STATES on Apr 07, 2008. Male patient, 65 years of age, weighting 222.7 lb, was diagnosed with myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, diverticulitis, liver function test abnormal. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, THYMOGLOBULIN, AZTREONAM, FLUCONAZOLE, METRONIDAZOLE, DILTIAZEM, FAMOTIDINE. Patient recovered.
Clolar Side Effects Report #5712088-6
Physician from UNITED STATES reported CLOLAR problem on Apr 14, 2008. Female patient, 16 years of age, was diagnosed with b precursor type acute leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, cholecystitis, hyperbilirubinaemia, mental status changes, pancytopenia. CLOLAR dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 03/08/2008.
Clolar Side Effects Report #5713811-7
CLOLAR problem was reported by a Physician from UNITED STATES on Apr 15, 2008. Male patient, child 12 years of age, weighting 80.25 lb, was diagnosed with acute lymphocytic leukaemia, myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, cardiomyopathy, chest pain, coagulopathy, dialysis, disease complication, febrile neutropenia, fibrosis. CLOLAR dosage: 36 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NALOXONE. Patient was hospitalized. Patient died on 01/10/2008.
Clolar Side Effects Report #5714026-9
Consumer or non-health professional from UNITED STATES reported CLOLAR problem on Apr 22, 2008. Male patient, weighting 136.7 lb, was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: dialysis, enterococcal infection, renal failure, respiratory failure, staphylococcal infection. CLOLAR dosage: 352 MG. During the same period patient was treated with CYTARABINE. Patient died.
Clolar Side Effects Report #5720929-1
CLOLAR problem was reported by a Physician from UNITED STATES on Apr 21, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: dialysis, enterococcal infection, hypoxia, neutropenic infection, refusal of treatment by relative, renal failure, respiratory failure, sepsis, staphylococcal infection. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 04/08/2008.
Clolar Side Effects Report #5720932-1
Physician from UNITED STATES reported CLOLAR problem on Apr 18, 2008. Male patient, 60 years of age, weighting 197.3 lb, was diagnosed with myelodysplastic syndrome and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: blood uric acid increased, diarrhoea, liver function test abnormal, oedema, pericardial effusion, rash. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, THYMOGLOBULINE, FLUCONAZOLE. Patient recovered.
Clolar Side Effects Report #5720944-8
CLOLAR problem was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, 65 years of age, weighting 222.7 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, diverticulitis, liver function test abnormal. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, THYMOGLOBULIN, AZTREONAM, FLUCONAZOLE, METRONIDAZOLE, DILTIAZEM, FAMOTIDINE. Patient recovered.
Clolar Side Effects Report #5728165-X
Physician from UNITED STATES reported CLOLAR problem on Apr 24, 2008. Female patient, 69 years of age, weighting 146.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: agitation, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, cardiac failure congestive, cardiomegaly, diarrhoea, disorientation. CLOLAR dosage: 76 MG, QD, INTRAVENOUS. During the same period patient was treated with CAMPATH, DILANTIN KAPSEAL, MELPHALAN. Patient was hospitalized. Patient recovered.
Clolar Side Effects Report #5728166-1
CLOLAR problem was reported by a Physician from UNITED STATES on Apr 24, 2008. Female patient, 65 years of age, weighting 222.7 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: diverticular perforation, diverticulitis, hypocalcaemia, large intestine perforation, liver function test abnormal. CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, AZTREONAM, FLUCONAZOLE, THYMOGLOBULIN, METRONIDAZOLE, DILTIAZEM, FAMOTIDINE. Patient recovered.
Clolar Side Effects Report #5346540-2
Physician from UNITED STATES reported CLOLAR problem on Jan 19, 2007. Female patient, 48 years of age, weighting 209.0 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, headache, nausea, vomiting. CLOLAR dosage: 82 MG DAILY IV. During the same period patient was treated with TAMBOCOR, PROTONIX, TRIMETHOPRIM, ALLOPURINOL, CLINDAMYCIN, LOPRESSOR, DILAUDID, AMBIEN. Patient recovered.
Clolar Side Effects Report #5346547-5
CLOLAR problem was reported by a Pharmacist from UNITED STATES on Feb 01, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. CLOLAR dosage: 30 MG/M2 QD X 5 IV. During the same period patient was treated with ALLOPURINOL, ESTRADIOL, PAROXETINE. Patient recovered.
Clolar Side Effects Report #5346548-7
Pharmacist from UNITED STATES reported CLOLAR problem on Feb 28, 2007. Male patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: pyrexia, rash pruritic, skin exfoliation. CLOLAR dosage: 36 MG/M2 QD IV. During the same period patient was treated with SEPTRA, ACYCLOVIR. Patient recovered.
Clolar Side Effects Report #5283028-1
CLOLAR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Female patient, weighting 223.5 lb, was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, acute respiratory distress syndrome, bacterial sepsis, haemorrhage, pulmonary oedema, serratia sepsis. CLOLAR dosage: 82.8 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Showing 1-40 of 74 Next >